Cargando…

Effectiveness of Pregabalin Treatment for Neuropathic Pain in Patients with Spine Diseases: A Pooled Analysis of Two Multicenter Observational Studies in Japan

PURPOSE: Neuropathic pain (NeP) is common among patients with chronic pain associated with spine diseases. Practical effectiveness of pregabalin, one of the first-line treatments for NeP, has not been evaluated in an entire population of patients with spine diseases, including various pathophysiolog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taguchi, Toshihiko, Nakano, Shogo, Nozawa, Kazutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981152/ https://www.ncbi.nlm.nih.gov/pubmed/33758538 http://dx.doi.org/10.2147/JPR.S293556

Ejemplares similares

A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With Chronic Cervical Pain With A Neuropathic Component In Japan
por: Akazawa, Manabu, et al.
Publicado: (2019)

Effectiveness of pregabalin for the treatment of chronic low back pain with accompanying lower limb pain (neuropathic component): a non-interventional study in Japan
por: Taguchi, Toshihiko, et al.
Publicado: (2015)

Direct and Indirect Pathways for Health-Related Quality of Life Change from Pain Improvement in Neuropathic Pain Patients with Spine Diseases: Path Analysis with Structural Equation Modeling Using Non-Interventional Study Results of Pregabalin
por: Taguchi, Toshihiko, et al.
Publicado: (2021)

Effectiveness of pregabalin for treatment of chronic cervical radiculopathy with upper limb radiating pain: an 8-week, multicenter prospective observational study in Japanese primary care settings
por: Taguchi, Toshihiko, et al.
Publicado: (2019)

The efficacy of pregabalin for the treatment of neuropathic pain in Japanese subjects with moderate or severe baseline pain
por: Parsons, Bruce, et al.
Publicado: (2019)

Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan
por: Igarashi, Ataru, et al.
Publicado: (2015)

Morphine and pregabalin in the treatment of neuropathic pain
por: Wang, Yue, et al.
Publicado: (2017)

Efficacy of Combination Therapy with Pregabalin in Neuropathic Pain: A Preclinical Study in the Rat L5 Spinal Nerve Ligation Model
por: Nozawa, Kazutaka, et al.
Publicado: (2022)

Pregabalin in Chemotherapy Induced Neuropathic Pain
por: Atreya, Shrikant
Publicado: (2016)

Pregabalin in the Treatment of Peripheral and Central Chronic Neuropathic Pain
por: Prnjavorac, Besim, et al.
Publicado: (2023)

Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
por: Verma, Vivek, et al.
Publicado: (2014)

Pregabalin Prescription for Neuropathic Pain and Fibromyalgia: A Descriptive Study Using Administrative Database in Japan
por: Hirakata, Mikito, et al.
Publicado: (2018)

Synergistic Antinociceptive Effects of Indomethacin–Pregabalin and Meloxicam–Pregabalin in Paclitaxel-Induced Neuropathic Pain
por: Ma, Yurong, et al.
Publicado: (2022)

Clinical use of pregabalin in the management of central neuropathic pain
por: Finnerup, Nanna B, et al.
Publicado: (2007)

Pregabalin in post traumatic neuropathic pain: Case studies
por: Singh, Rakesh Kumar, et al.
Publicado: (2012)

Duloxetine and pregabalin in neuropathic pain of lung cancer patients
por: Gül, Şule Karabulut, et al.
Publicado: (2020)

Barriers to healthcare access in patients with chronic pain or potential migraine in Japan: a cross-sectional internet survey
por: Karasawa, Yusuke, et al.
Publicado: (2023)

Pregabalin treatment for neuropathic pain may damage intervertebral disc tissue
por: Karaarslan, Numan, et al.
Publicado: (2018)

Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin
por: Enomoto, Hiroyuki, et al.
Publicado: (2018)

Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies
por: Semel, David, et al.
Publicado: (2010)

Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
por: Martinez, Jose A, et al.
Publicado: (2012)

A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain
por: Freynhagen, Rainer, et al.
Publicado: (2015)

The antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system
por: Kremer, Mélanie, et al.
Publicado: (2016)

Effect of duloxetine on neuropathic pain in patients intolerant to continuous administration of pregabalin
por: Shimada, Yohei, et al.
Publicado: (2017)

A Prospective Observational Study Comparing the Efficacy and Safety of Duloxetine and Pregabalin in Diabetic Peripheral Neuropathic Pain
por: Shah, Islam, et al.
Publicado: (2022)

Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
por: Quilici, Sibilia, et al.
Publicado: (2009)

Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis
por: De Santis, Stefano, et al.
Publicado: (2016)

Retraction: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
por: Martinez, Jose A, et al.
Publicado: (2014)

Sustained-release pregabalin with methylcobalamin in neuropathic pain: an Indian real-life experience
por: Dongre, Yasmin U, et al.
Publicado: (2013)

Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain
por: Haanpää, M., et al.
Publicado: (2015)

Factors predicting adverse events associated with pregabalin administered for neuropathic pain relief
por: Kanbayashi, Yuko, et al.
Publicado: (2014)

Add-On Treatment with Pregabalin for Patients with Uncontrolled Neuropathic Pain Who Have Been Referred to Pain Clinics
por: de la Calle, José-Luis, et al.
Publicado: (2014)

Antiallodynic Effect of Pregabalin in Rat Models of Sympathetically Maintained and Sympathetic Independent Neuropathic Pain
por: Han, Dong Woo, et al.
Publicado: (2007)

Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review
por: Plested, Melanie, et al.
Publicado: (2010)

Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials
por: Freeman, Roy, et al.
Publicado: (2015)

Response to pregabalin and progesterone differs in male and female rat models of neuropathic and cancer pain
por: Ungard, Robert G., et al.
Publicado: (2020)

Neuropathic Pain Creates Systemic Ultrastructural Changes in the Nervous System Corrected by Electroacupuncture but Not by Pregabalin
por: Gao, Lei, et al.
Publicado: (2021)

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
por: Tesfaye, Solomon, et al.
Publicado: (2022)

Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland
por: Mankowski, Colette, et al.
Publicado: (2016)

Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity
por: Sicras‐Mainar, Antoni, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_92jn9fttjfrck6la7m039e8hdf